New polypill shows promise in slowing Alzheimer's decline

NCT ID NCT06597058

First seen Apr 15, 2026 · Last updated May 02, 2026 · Updated 3 times

Summary

This study tested a fixed-dose combination pill (polypill) in 121 people aged 50-85 with very mild to severe Alzheimer's disease. Over 180 days of treatment, researchers measured changes in memory, thinking, and daily function using standard tests. The goal was to see if the pill could slow or improve symptoms compared to a placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Accel Research Sites (Noah Clinical Site 019)

    DeLand, Florida, 32720, United States

  • Best Choice Medical and Research Service (Noah Clinical Site 025)

    Pembroke Pines, Florida, 33024, United States

  • Boston Clinical Trials (Noah Clinical Site 006)

    Boston, Massachusetts, 02131, United States

  • Carolina Research Center, Inc. (Noah Clinical Site 009)

    Shelby, North Carolina, 28150, United States

  • Denali Health Plant City, LLC (Noah Clinical Site 024)

    Plant City, Florida, 33563, United States

  • Health Awareness (Noah Clinical Site 020)

    Jupiter, Florida, 33458, United States

  • IMA Clinical Research (Noah Clinical Site 004)

    Albuquerque, New Mexico, 87109, United States

  • International Medical Investigational Centers (Noah Clinical Site 001)

    Palmetto Bay, Florida, 33176, United States

  • Life Well Research Center (Noah Clinical Site 008)

    Miami, Florida, 33134, United States

  • Marvel Clinical Research (Noah Clinical Site 010)

    Huntington Beach, California, 92647, United States

  • Miami Jewish Health (Noah Clinical Site 023)

    Miami, Florida, 33137, United States

  • Neurology Associates of Ormond Beach (Noah Clinical Site 015)

    Ormond Beach, Florida, 32174, United States

  • Olympus Clinical Research (Noah Clinical Site 014)

    Katy, Texas, 77450, United States

  • Regenerate Primary Medical Research (Noah Clinical Site 003)

    Miami, Florida, 33134, United States

  • Scottsdale Clinical Trials (Noah Clinical Site 017)

    Scottsdale, Arizona, 85260, United States

  • Tekton Research (Noah Clinical Site 002)

    Yukon, Oklahoma, 73099, United States

Conditions

Explore the condition pages connected to this study.